Funder: Food and Drug Administration
Due Dates: Forecasted (no current deadline posted)
Funding Amounts: $350,000 (single award; cooperative agreement)
Summary: Supports research to identify, evaluate, and implement approaches to reduce nitrosamine impurities in drugs, improving public safety and ensuring continued access to essential medications.
Key Information: This is a forecasted opportunity; application details and deadlines are not yet posted.